DuckWiseDuckWise Get the app

Archive › MRK

MRK trade ideas: every closed DuckWise idea on Merck & Company, Inc.

DuckWise has published 3 ideas on Merck & Company, Inc. (MRK, Stock) that have closed between May 2020 and October 2021. Each is listed below with the levels published before the position was taken and its result at close — 3 in profit, 0 at a loss.

3closed ideas
3 / 0in profit / at a loss
+11.13%average result
49 daystypical holding period
OpenedClosedSideEntryStopProjectionCloseResultDays
Feb 4, 2021Oct 4, 2021Long75.86—8883.57+12.81%
incl. +2.65% div.
242
Jun 15, 2020Aug 3, 2020Long74.40—87.2583.58+12.34%49
May 22, 2020Jun 3, 2020Long76.38—8382.67+8.24%12

Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. How results are counted.

MRK questions and answers

Has DuckWise published trade ideas on MRK?

Yes. DuckWise has published 3 ideas on Merck & Company, Inc. (MRK) that closed between May 2020 and October 2021: 3 closed in profit and 0 at a loss. The average result was +11.13% from the published entry to the published close, dividends included.

What was the latest closed DuckWise idea on MRK?

A long idea opened on February 4, 2021 with an entry of $75.86 and a price projection of $88.00. It closed on October 4, 2021 at $83.57, a result of +12.81% after 242 days.

How long did DuckWise hold its MRK ideas?

The typical MRK idea was held about 49 days from entry to close. DuckWise ideas are swing and position trades, not day trades.

Is there an open DuckWise idea on MRK right now?

Not at the moment. When DuckWise publishes a new idea on MRK, app subscribers get a push notification; it appears on this page once it closes.

Is this page a stock forecast for MRK or a recommendation to buy it?

No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where MRK will trade. The research is general and impersonal, not a recommendation to buy or sell MRK or any other security.

More trade ideas on the record

Every ticker in the archive · Track record by year

About Merck & Company, Inc.

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. Pays a dividend yield of 2.30% annually.

These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell MRK or any other security.